Advanced search
Publication Cover
Cell Cycle Volume 17, 2018 - Issue 10
Submit an article Journal homepage
1,600
Views
31
CrossRef citations to date
0
Altmetric
Research Paper

Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel

Haifeng Qiua Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Jing Lib Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
View further author information
,
Qiuli Liuc Department of Obstetrics and Gynecology, the Affiliated Hospital of Jiangnan University, Wuxi, ChinaView further author information
,
Mei Tangc Department of Obstetrics and Gynecology, the Affiliated Hospital of Jiangnan University, Wuxi, ChinaView further author information
&
Yuan Wangc Department of Obstetrics and Gynecology, the Affiliated Hospital of Jiangnan University, Wuxi, ChinaView further author information
Pages 1235-1244 | Received 07 Dec 2017, Accepted 23 Apr 2018, Published online: 17 Jul 2018

References

  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. PubMed PMID: 26808342.
  • Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. PubMed PMID: 25651787.
  • Mountzios G, Soultati A, Pectasides D, et al. Developments in the systemic treatment of metastatic cervical cancer. Cancer Treat Rev. 2013;39(5):430–443. PubMed PMID: 22727690.
  • Tian S, Quan H, Xie C, et al. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo. Cancer Sci. 2011;102(7):1374–1380. PubMed PMID: 21443688.
  • Li J, Qin S, Xu J, et al. Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol. 2016;34(13):1448–1454. PubMed PMID: 26884585.
  • Hu X, Zhang J, Xu B, et al. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer. Int J Cancer. 2014;135(8):1961–1969. PubMed PMID: 24604288.
  • Li F, Zhu T, Cao B, et al. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance. Eur J Cancer. 2017;84:184–192. PubMed PMID: 28822888.
  • Peng H, Zhang Q, Li J, et al. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. Oncotarget. 2016;7(13):17220–17229. PubMed PMID: 26967384.
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. PubMed PMID: 21376230.
  • Zhu P, Hu C, Hui K, et al. The role and significance of VEGFR2(+) regulatory T cells in tumor immunity. Onco Targets Ther. 2017;10:4315–4319. PubMed PMID: 28919780.
  • Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23(5):1011–1027. PubMed PMID: 15585754.
  • Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13(12):871–882. PubMed PMID: 24263190.
  • Smith GA, Fearnley GW, Abdul-Zani I, et al. Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function. Biol Open. 2017;6(10):1404–1415. PubMed PMID: 28798148.
  • Branca M, Giorgi C, Santini D, et al. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol. 2006;59(1):40–47. PubMed PMID: 16394279.
  • Chen B, Zhang C, Dong P, et al. Molecular regulation of cervical cancer growth and invasion by VEGFa. Tumour Biol. 2014;35(11):11587–11593. PubMed PMID: 25135429.
  • Goncharuk IV, Vorobjova LI, Lukyanova NY, et al. Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival. Exp Oncol. 2009;31(3):179–181. PubMed PMID: 19783962.
  • Hammes LS, Tekmal RR, Naud P, et al. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol Oncol. 2008;110(3):445–451. PubMed PMID: 18565574.
  • Liu K, Ren T, Huang Y, et al. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma. Cell Death Dis. 2017;8(8):e3015. PubMed PMID: 28837148.
  • Lin C, Wang S, Xie W, et al. Apatinib inhibits cellular invasion and migration by fusion kinase KIF5B-RET via suppressing RET/Src signaling pathway. Oncotarget. 2016;7(37):59236–59244. PubMed PMID: 27494860.
  • Mi YJ, Liang YJ, Huang HB, et al. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Res. 2010;70(20):7981–7991. PubMed PMID: 20876799.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.